Value of percutaneous transhepatic cholangioscopy (PTCS)

Prior research has shown that biliary tract diseases require accurate diagnosis and targeted treatment. Established knowledge includes the use of percutaneous transhepatic biliary drainage for managing bile duct obstructions. However, a gap remained in combining diagnostic precision with therapeutic intervention in the same procedure. That uncertainty drove the development of more advanced tools for biliary tract exploration. No prior work had resolved the need for a method that could both visualize and treat biliary lesions. This gap motivated the refinement of endoscopic approaches to improve outcomes. The need for a minimally invasive method to assess and treat biliary pathology became increasingly evident. This paper contributes by introducing a technique that addresses both diagnostic and therapeutic challenges.

The aim of this work was to evaluate the clinical utility of percutaneous transhepatic cholangioscopy. The specific problem addressed was the need for a method that could provide both accurate diagnosis and targeted treatment of biliary tract conditions. The motivation stemmed from the limitations of existing drainage techniques, which lacked the ability to directly visualize and sample lesions. This study sought to determine the effectiveness of PTCS in both malignant and benign cases. The researchers proposed that PTCS could reduce the need for multiple procedures by combining diagnostic and therapeutic functions. The study also aimed to assess the safety profile of PTCS in a large clinical cohort. The goal was to establish whether PTCS could serve as a reliable alternative to traditional methods. By evaluating outcomes in a broad patient population, the study aimed to define the scope of PTCS applicability.

The study involved a retrospective analysis of 393 patients who underwent PTCS procedures. The technique was performed through a pre-established percutaneous transhepatic biliary drainage tract. A 15-Fr catheter was used to dilate the tract approximately two weeks after initial drainage. The cholangioscopy was then inserted through the dilated sinus tract to visualize the biliary system. Biopsy samples were obtained for histological analysis in malignant cases. For gallstone disease, the procedure was used to perform lithotripsy. The Nd-YAG laser and electrohydraulic shock wave were the primary tools for stone fragmentation. The researchers recorded procedural outcomes, including complication rates and success in lesion assessment.

The study found that PTCS provided accurate histological diagnosis in 198 cases of malignant biliary disease. Lesion extent was assessed pre-operatively in all malignant cases through biopsy. In benign conditions, PTCS was used in 195 cases, primarily for gallstone treatment. Cholangioscopic lithotripsy was performed in 145 gallstone cases. Of these, 44 cases utilized the Nd-YAG laser or electrohydraulic shock wave for stone fragmentation. The overall morbidity rate associated with PTCS was 6%. The mortality rate was 0.3%, indicating a relatively low risk profile. These findings suggest that PTCS is both effective and safe for biliary tract interventions.

The authors propose that PTCS is a valuable tool for both diagnosing and treating biliary tract conditions. They suggest that the technique allows for accurate histological assessment of lesions before surgery. The study supports the use of PTCS in malignant cases to determine cancer extent. The researchers propose that PTCS can reduce the need for multiple procedures in gallstone disease. The low complication rate suggests that the technique is relatively safe. The authors suggest that PTCS is particularly useful in cases where traditional methods are insufficient. The findings indicate that PTCS can serve as an alternative to more invasive approaches. The study concludes that PTCS offers a combined diagnostic and therapeutic benefit in biliary tract disease.